Verastem (VSTM) Share-based Compensation (2011 - 2026)
Verastem (VSTM) recorded quarterly Share-based Compensation of $2.0 million in Q1 2026, up 1.04% quarter-over-quarter from $2.0 million in Q4 2025, and up 14.43% on a YoY basis from $1.8 million in Q1 2025.
Verastem (VSTM) Share-based Compensation (2011 - 2026) Analysis & Trends
Verastem's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 14.43% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $9.7 million (up 26.35% YoY), while the FY2025 annual figure was $9.4 million, up 28.08% from the prior year.
- Share-based Compensation was $2.0 million for Q1 2026 at Verastem, up from $2.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.4 million in Q2 2025 to a low of $1.3 million in Q4 2022.
- Historically, Share-based Compensation has averaged $1.8 million across 5 years, with a median of $1.8 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation sank 31.76% in 2022, then soared 79.16% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $1.3 million in 2022, then advanced by 24.16% to $1.6 million in 2023, then grew by 26.35% to $2.0 million in 2024, then climbed by 0.3% to $2.0 million in 2025, then rose by 1.04% to $2.0 million in 2026.
- The last three Share-based Compensation figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |